SEC Form 4 · accession 0001127602-19-006806
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald G Gelbman
Director
Period of report
Feb 15, 2019
Accepted (ET)
Feb 19, 2019 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 15, 2019 | M | 8,196 | $36.37 | A | 61,258 | D | |
| Common StockF1 | Feb 15, 2019 | S | 8,196 | $86.52 | D | 53,062 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F2 | $36.37 | Feb 15, 2019 | M | 8,196 | D | Jul 27, 2013 | Jul 27, 2019 | Common Stock | 8,196 | 0 | D |
Explanation of responses
- F1This number includes unvested restricted stock units previously reported.
- F2Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.